Mesenchymal stem cell-derived extracellular vesicles as a new therapeutic strategy for ocular diseases-Reference-Cited by-同舟云学术

Mesenchymal stem cell-derived extracellular vesicles as a new therapeutic strategy for ocular diseases

Published:2020-03-26 Issue:3 Volume:12 Page:178-187
ISSN:1948-0210
Container-title:World Journal of Stem Cells
language:
Short-container-title:WJSC

Author:

Yu Bo,Li Xiao-Rong,Zhang Xiao-Min

Publisher

Baishideng Publishing Group Inc.

Subject

Cell Biology,Genetics (clinical),Genetics,Molecular Biology,Histology

Reference81 articles.

1. Sensor-Based Assistive Devices for Visually-Impaired People: Current Status, Challenges, and Future Directions

2. Global causes of blindness and distance vision impairment 1990–2020: a systematic review and meta-analysis

3. Vascular Regeneration for Ischemic Retinopathies: Hope from Cell Therapies

4. Apolipoprotein E-Mimetic Peptide COG1410 Enhances Retinal Ganglion Cell Survival by Attenuating Inflammation and Apoptosis Following TONI

5. Kohen MC, Tatlipinar S, Cumbul A, Uslu Ü. The effects of bevacizumab treatment in a rat model of retinal ischemia and perfusion injury. Mol Vis 2018; 24: 239-250

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mesenchymal stem cell therapy in veterinary ophthalmology: clinical evidence and prospects;Veterinary Research Communications;2024-08-30

2. Small extracellular vesicles derived from microRNA-22-3p-overexpressing mesenchymal stem cells protect retinal ganglion cells by regulating MAPK pathway;Communications Biology;2024-07-03

3. Regenerative mechanisms of stem cells and their clinical applications for degenerative eye diseases;Journal of Research in Medical Sciences;2024-07

4. Current Strategies and Therapeutic Applications of Mesenchymal Stem Cell-Based Drug Delivery;Pharmaceuticals;2024-05-30

5. Exploring Stem-Cell-Based Therapies for Retinal Regeneration;Life;2024-05-23